Belluscura plc

BELL

GB00BD3B8Z11

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. Other stock markets 07:30:00 01/07/2025 BST			5-day change	1st Jan Change
0.7500 ^GBX	0.00%		+3.45%	-91.89%

06-30	EARNINGS AND TRADING: TT Electronics revenue falls; Capai in profit	AN
06-30	Belluscura Unit Obtains Short-term Convertible Loan Note	MT

Medical device maker Belluscura expects 20% tariff on products sold in US

Published on 16/04/2025 at 08:54

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Belluscura plc

EARNINGS AND TRADING: TT Electronics revenue falls; Capai in profit	06-30	AN
Belluscura Unit Obtains Short-term Convertible Loan Note	06-30	MT
Belluscura plc Provides Strategic Review Update	06-30	CI
Firms Scrap Forecasts Under Tariff Strain	05-26
Companies withdraw guidance amid Trump's tariffs	05-26	RE
Companies withdraw guidance amid Trump's tariffs	05-16	RE
Belluscura Says No New 'Notifiable Developments' as Shares Surge	05-13	MT
Belluscura notes share price rise, says no news since Friday	05-13	AN
Belluscura launches strategic review as seeks working capital boost	05-09	AN
Europe rises following US-Germany phone call	05-09	AN
AIM WINNERS & LOSERS: Conroy Gold hails Clontibret potential	05-09	AN
Belluscura Launches Strategic Review to Boost Capital Position	05-09	MT
Belluscura Commences Strategic Review	05-09	CI
Belluscura Announces Commencement Of Strategic Review	05-09	RE
Companies withdraw guidance amid Trump's tariffs	05-07	RE
Companies withdraw guidance amid Trump's tariffs	05-02	RE
Companies withdraw guidance amid Trump's tariffs	04-30	RE
Belluscura CFO to Step Down in May	04-16	MT
Medical device maker Belluscura expects 20% tariff on products sold in US	04-16	RE
Medical device maker Belluscura expects 20% tariff on products sold in US	04-16	RE
UK medical device maker Belluscura expects 20% tariff on products sold in US	04-16	RE
FTSE 100 down as UK consumer inflation eases	04-16	AN
Belluscura Says CFO Simon Neicheril Resigns	04-16	RE
Belluscura withdraws 2025 outlook over U.S. tariff impact	04-08	RE
AIM WINNERS & LOSERS: Belluscura withdraws guidance on tariff fears	04-08	AN

Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

09-07 - Q2 2025 Earnings Release (Projected)

More about the company